GlassScriptPhysician profile
Jameel Ahmed
NPI 1326094996
$44,257.95
in general payments reported to CMS, 2019-2025
31 companies · $1,589 in 2025
The $1,589 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $12K · 2021: $9,226 · 2022: $4,196 · 2023: $571 · 2024: $401 · 2025: $1,589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,657 · Travel and Lodging: $904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,656.67 |
| Travel and Lodging | $904.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $27,213.99 | 2019-2020 | |
| Medtronic, INC. | $13,347.65 | 2021-2025 | Linq II, Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Abbott Laboratories | $1,646.22 | 2019-2025 | Aveir, Jot Dx, Gallant |
| Biotronik INC. | $506.51 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $315.84 | 2019-2024 | Lifevest |
| Biosense Webster, INC. | $186.62 | 2021-2025 | Carto 3, Qdot Micro Catheter |
| Janssen Pharmaceuticals, INC | $141.93 | 2020-2023 | Xarelto |
| Siemens Medical Solutions USA, INC. | $96.49 | 2025 | Artis Icono Biplane |
| E.R. Squibb & Sons, L.L.C. | $71.59 | 2019-2024 | Camzyos |
| Xeris Pharmaceuticals, INC. | $61.36 | 2024-2025 | Recorlev, Gvoke Hypopen |
| Boston Scientific Corporation | $57.61 | 2019-2025 | Watchman Flx |
| Actelion Pharmaceuticals US, INC. | $50.53 | 2019 | |
| Irhythm Technologies, INC. | $49.86 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Astrazeneca Pharmaceuticals LP | $48.81 | 2022 | |
| Atricure, INC. | $48.79 | 2023 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $48.58 | 2019-2025 | |
| Pfizer INC. | $40.08 | 2019 | |
| Abbvie INC. | $39.51 | 2024 | |
| Baxter Healthcare | $36.13 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Philips North America LLC | $32.69 | 2024 | (Am5) Lead Management |
| Kestra Medical Technology Services, INC. | $30.29 | 2022-2024 | Assure Wcd |
| Gilead Sciences, INC. | $28.81 | 2019 | |
| Amgen INC. | $23.29 | 2025 | Uplizna |
| Bayer Healthcare Pharmaceuticals INC. | $22.56 | 2019 | |
| Cardiofocus, INC. | $22.48 | 2021 | |
| Neurocrine Biosciences, INC. | $20.71 | 2020 | |
| Genentech USA, INC. | $18.70 | 2024 | Ocrevus |
| United Therapeutics Corporation | $18.47 | 2019 | |
| Stereotaxis INC | $17.41 | 2022 | |
| Sandoz INC. | $14.44 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jameel Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.